Antiviral activity of narlaprevir combined with ritonavir and pegylated interferon in chronic hepatitis C patients.
de Bruijne J, Bergmann JF, Reesink HW, Weegink CJ, Molenkamp R, Schinkel J, Tong X, Li J, Treitel MA, Hughes EA, van Lier JJ, van Vliet AA, Janssen HL, de Knegt RJ.
de Bruijne J, et al. Among authors: weegink cj.
Hepatology. 2010 Nov;52(5):1590-9. doi: 10.1002/hep.23899.
Hepatology. 2010.
PMID: 20938912
Clinical Trial.